The Status of Hypertriglyceridemia as a Risk Factor for Coronary Heart Disease

Clinics in Laboratory Medicine - Tập 9 Số 1 - Trang 153-168 - 1989
Andrew L. Avins1, Richard J. Haber1, Stephen B. Hulley1
1From the Departments of Medicine and Clinical Epidemiology, University of California, San Francisco, and the Division of General Internal Medicine, San Francisco General Hospital, San Francisco, California

Tóm tắt

Từ khóa


Tài liệu tham khảo

Aberg, 1985, Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris, Atherosclerosis, 54, 89, 10.1016/0021-9150(85)90156-X

Barrett-Connor, 1987, Borderline fasting hypertriglyceridemia: Absence of excess risk of all-cause and cardiovascular disease mortality in healthy men without hypercholesterolemia, Prev Med, 16, 1, 10.1016/0091-7435(87)90001-6

Blankenhorn, 1987, Beneficial effects of combined colesti-pol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts, JAMA, 257, 3233, 10.1001/jama.1987.03390230069027

Brunzell, 1982, Chylomicronemia syndrome: Interactions of genetic and acquired hypertriglyceridemia, Med Clin North Am, 66, 455, 10.1016/S0025-7125(16)31430-4

Cambien, 1986, Is the level of serum triglyceride a significant predictor of coronary death in “normocholesterolemic” subjects?, Am J Epidemiol, 124, 624, 10.1093/oxfordjournals.aje.a114435

Canner, 1986, Fifteen year mortality in coronary drug project patients: Long-term benefit with niacin, J Am Coll Cardiol, 8, 1245, 10.1016/S0735-1097(86)80293-5

Carlson, 1985, Risk factors for ischaemic heart disease in men and women, Acta Med Scand, 218, 207, 10.1111/j.0954-6820.1985.tb08848.x

Carlson, 1981, Serum triglycerides, to be or not to be a risk factor for ischaemic heart disease?, Atherosclerosis, 39, 287, 10.1016/0021-9150(81)90014-9

Copeland, 1977, Bias due to misclassification in the sestimation of relative risk, Am J Epidemiol, 105, 488, 10.1093/oxfordjournals.aje.a112408

Criqui, 1987, Triglycerides and coronary heart disease mortality. The Lipid Research Clinics Follow-up study, CVD Epidemiology Newsletter (abstract), 41, 13

Eisenberg, 1987, Lipoprotein abnormalities in HTG: Significance in atherosclerosis, Am Heart J, 113, 555, 10.1016/0002-8703(87)90632-6

1988, Expert Panel: Report of the National Cholesterol Education Program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults, Arch Intern Med, 148, 36, 10.1001/archinte.1988.00380010040006

Fager, 1981, Multivariate analyses of serum apolipoproteins and risk factors in relation to acute myocardial infarction, Arteriosclerosis, 1, 273, 10.1161/01.ATV.1.4.273

Freedman, 1988, Relation of triglyceride levels to coronary artery disease: The Milwaukee cardiovascular data registry, Am J Epidemiol, 127, 1118, 10.1093/oxfordjournals.aje.a114906

Freiman, 1978, The importance of the beta, or type II, error and sample size in the design and interpretation of the randomized controlled trial: Survey of 71 “negative” trials, N Engl J Med, 299, 690, 10.1056/NEJM197809282991304

Frick, 1987, Helsinki heart study: Primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia, N Engl J Med, 317, 1237, 10.1056/NEJM198711123172001

Friedwald, 1972, Estimation of the concentration of low-den-sity lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem, 18, 499, 10.1093/clinchem/18.6.499

Glynn, 1982, Changes in cholesterol and triglyceride as predictors of ischemic heart disease in men, Circulation, 66, 724, 10.1161/01.CIR.66.4.724

Goldstein, 1973, Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia, J Clin Invest., 52, 1544, 10.1172/JCI107332

Grundy, 1982, HTG: Mechanisms, clinical significance, and treatment, Med Clin North Am, 66, 521, 10.1016/S0025-7125(16)31433-X

Hamsten, 1986, Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction, Atherosclerosis, 59, 223, 10.1016/0021-9150(86)90051-1

Hey, 1980, Fasting triglycerides as predictors of total and CHD mortality in Evans County, Georgia, J Chron Dis, 33, 275, 10.1016/0021-9681(80)90022-3

Hoeg, 1986, An approach to the management of hyperlipoproteinemia, JAMA, 255, 512, 10.1001/jama.1986.03370040086030

Hollister, 1964, Comparative variability of serum cholesterol and serum triglycerides, Am J Med Sci, 248, 329, 10.1097/00000441-196409000-00009

Holmes, 1981, Association of risk factor variables andcoronary artery disease documented with angiography, Circulation, 63, 293, 10.1161/01.CIR.63.2.293

Hopkins, 1986, Identification and relative weight of cardiovascular riskfactors, Cardiol Clin, 4, 3, 10.1016/S0733-8651(18)30632-5

Hulley, 1980, Epidemiology as a guide to clinical decisions: The association between triglyceride and coronary heart disease, N Engl J Med, 302, 1383, 10.1056/NEJM198006193022503

Jacobs, 1982, Retest reliability of plasma cholesterol and triglyceride, Am J Epidemiol, 116, 878, 10.1093/oxfordjournals.aje.a113490

Kameda, 1984, Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan, Atherosclerosis, 51, 241, 10.1016/0021-9150(84)90171-0

Kaukola, 1980, Serum lipids with special reference to HDL cholesterol and triglycerides in young male survivors of acute myocardial infarction, Acta Med Scand, 208, 41, 10.1111/j.0954-6820.1980.tb01147.x

Kelsey, 1986, 285

Kleinbaum, 1982, 78

Kukita, 1982, Plasma lipids and lipoproteins in Japanese male patients with coronary artery disease and in their relatives, Atherosclerosis, 42, 21, 10.1016/0021-9150(82)90122-8

Lapidus, 1985, Triglycerides—main lipid risk factor for cardiovascular disease in women?, Acta Med Scand, 217, 481, 10.1111/j.0954-6820.1985.tb03251.x

Lavie, 1988, Management of lipids in primary and secondary prevention of cardiovascular disease, Mayo Clin Proc, 63, 605, 10.1016/S0025-6196(12)64891-5

Levy, 1984, The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: Results of the NHLBI Type II coronary intervention study, Circulation, 69, 325, 10.1161/01.CIR.69.2.325

1984, The lipid research clinics coronary primary prevention trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering, JAMA, 251, 365, 10.1001/jama.1984.03340270043026

Mannienen, 1988, Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki heart study, JAMA, 260, 641, 10.1001/jama.1988.03410050061031

Miller, 1981, Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins, Br Med J, 282, 1741, 10.1136/bmj.282.6278.1741

Motulsky, 1976, Current concepts in genetics: The genetic hyperlipidemias, N Engl J Med, 294, 823, 10.1056/NEJM197604082941507

1984, Treatment of hypertriglyceridemia, JAMA, 251, 1196, 10.1001/jama.1984.03340330054025

Nestel, 1987, Is serum triglyceride an independent predictor of coronary artery disease?, Pract Cardiol, 13, 96

Perry, 1986, Contemporary recommendations for evaluating and treating hyperlipidemia, Clin Pharm, 5, 113

Petersson, 1984, Premature death and associated risk factors in urban middle-aged men, Am J Med, 77, 418, 10.1016/0002-9343(84)90096-2

Philippi, 1984, Fasting plasma glucose, uric acid, and triglycerides as predictors of the ratio of total cholesterol to HDL-C, Am J Clin Pathol, 82, 329, 10.1093/ajcp/82.3.329

Reardon, 1985, Lipoprotein predictors of the severity of coronary artery disease in men and women, Circulation, 71, 881, 10.1161/01.CIR.71.5.881

Rhoads, 1983, Serum triglyceride and risk of coronary heart disease, stroke and total mortality in Japanese-American men, Arteriosclerosis, 3, 316, 10.1161/01.ATV.3.4.316

Rosenhamer, 1980, Effect of combined clofibrate-nicotinic acid treatment in ischemic heart disease, Atherosclerosis, 37, 129, 10.1016/0021-9150(80)90100-8

Salonen, 1983, Relation of serum cholesterol and triglycerides to the risk of acute myocardial infarction, cerebral stroke and death in eastern Finnish male population, Int J Epidemiol, 12, 26, 10.1093/ije/12.1.26

Scheidt, 1986, Lipid regulation: A clinician′s view of patient management, Am Heart J, 112, 437, 10.1016/0002-8703(86)90297-8

Shaper, 1985, Risk factors for ischaemic heart disease: The prospective phase of the British regional heart study, J Epidemiol Comm Health, 39, 197, 10.1136/jech.39.3.197

Simons, 1986, Interrelations of lipids and lipoproteins with coronary artery disease mortality in 19 countries, Am J Cardiol, 57, 5G, 10.1016/0002-9149(86)90659-4

Thind, 1981, Signification of high density and total cholesterol and triglycerides in acute myocardial infarction—a case-control study, Clin Biochem, 14, 57, 10.1016/S0009-9120(81)90670-6

Tibblin, 1963, Serum lipids during the course of an acute myocardial infarction and one year afterwards, Acta Med Scand, 174, 451, 10.1111/j.0954-6820.1963.tb07944.x

Wallace, 1987, Blood lipids, lipid-related measures, and the risk of atherosclerotic cardiovascular disease, Epidem Rev, 9, 95, 10.1093/oxfordjournals.epirev.a036310

Warnick, 1975, Physiological and analytical variation in cholesterol and triglycerides, Lipids, 11, 203, 10.1007/BF02532858

Wieland, 1980, Serum lipoproteins and coronary artery disease, Atherosclerosis, 36, 269, 10.1016/0021-9150(80)90235-X

Witztum, 1980, Normalization of triglycerides in type IV hyperlipoproteinemia fails to correct low levels of high-density lipoprotein cholesterol, N Engl J Med, 303, 907, 10.1056/NEJM198010163031603

Zampogna, 1980, Relationship between lipids and occlusive coronary artery disease, Arch Intern Med, 140, 1067, 10.1001/archinte.1980.00330190079024